nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclopentolate—Bromodiphenhydramine—Tamoxifen—pancreatic cancer	0.315	0.403	CrCrCtD
Cyclopentolate—Orphenadrine—Tamoxifen—pancreatic cancer	0.247	0.316	CrCrCtD
Cyclopentolate—Diphenhydramine—Tamoxifen—pancreatic cancer	0.22	0.281	CrCrCtD
Cyclopentolate—BCHE—Irinotecan—pancreatic cancer	0.114	1	CbGbCtD
Cyclopentolate—Paralysis—Tamoxifen—pancreatic cancer	0.00173	0.0455	CcSEcCtD
Cyclopentolate—Lacrimation—Irinotecan—pancreatic cancer	0.00144	0.0379	CcSEcCtD
Cyclopentolate—Lacrimation—Fluorouracil—pancreatic cancer	0.00138	0.0363	CcSEcCtD
Cyclopentolate—Lacrimation increased—Sunitinib—pancreatic cancer	0.00112	0.0294	CcSEcCtD
Cyclopentolate—Lacrimation—Docetaxel—pancreatic cancer	0.000998	0.0262	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Irinotecan—pancreatic cancer	0.000966	0.0254	CcSEcCtD
Cyclopentolate—Vasodilation—Irinotecan—pancreatic cancer	0.000966	0.0254	CcSEcCtD
Cyclopentolate—Lacrimation increased—Irinotecan—pancreatic cancer	0.000921	0.0242	CcSEcCtD
Cyclopentolate—Lacrimation increased—Fluorouracil—pancreatic cancer	0.000882	0.0232	CcSEcCtD
Cyclopentolate—Photophobia—Fluorouracil—pancreatic cancer	0.000763	0.0201	CcSEcCtD
Cyclopentolate—Coma—Fluorouracil—pancreatic cancer	0.000743	0.0195	CcSEcCtD
Cyclopentolate—Lacrimation—Epirubicin—pancreatic cancer	0.000673	0.0177	CcSEcCtD
Cyclopentolate—Disorientation—Fluorouracil—pancreatic cancer	0.00066	0.0173	CcSEcCtD
Cyclopentolate—Abdominal distension—Sunitinib—pancreatic cancer	0.000651	0.0171	CcSEcCtD
Cyclopentolate—Conjunctivitis—Erlotinib—pancreatic cancer	0.000647	0.017	CcSEcCtD
Cyclopentolate—Lacrimation increased—Docetaxel—pancreatic cancer	0.000637	0.0167	CcSEcCtD
Cyclopentolate—Lacrimation—Doxorubicin—pancreatic cancer	0.000623	0.0164	CcSEcCtD
Cyclopentolate—Paralysis—Epirubicin—pancreatic cancer	0.00057	0.015	CcSEcCtD
Cyclopentolate—Flushing—Tamoxifen—pancreatic cancer	0.000561	0.0147	CcSEcCtD
Cyclopentolate—Ataxia—Fluorouracil—pancreatic cancer	0.000555	0.0146	CcSEcCtD
Cyclopentolate—Abdominal distension—Irinotecan—pancreatic cancer	0.000536	0.0141	CcSEcCtD
Cyclopentolate—Paralysis—Doxorubicin—pancreatic cancer	0.000527	0.0139	CcSEcCtD
Cyclopentolate—Flushing—Sunitinib—pancreatic cancer	0.00048	0.0126	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Epirubicin—pancreatic cancer	0.00045	0.0118	CcSEcCtD
Cyclopentolate—Vasodilation—Epirubicin—pancreatic cancer	0.00045	0.0118	CcSEcCtD
Cyclopentolate—Conjunctivitis—Fluorouracil—pancreatic cancer	0.000442	0.0116	CcSEcCtD
Cyclopentolate—Dry mouth—Tamoxifen—pancreatic cancer	0.000438	0.0115	CcSEcCtD
Cyclopentolate—Lacrimation increased—Epirubicin—pancreatic cancer	0.000429	0.0113	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Doxorubicin—pancreatic cancer	0.000417	0.011	CcSEcCtD
Cyclopentolate—Vasodilation—Doxorubicin—pancreatic cancer	0.000417	0.011	CcSEcCtD
Cyclopentolate—Coordination abnormal—Epirubicin—pancreatic cancer	0.000403	0.0106	CcSEcCtD
Cyclopentolate—Ataxia—Docetaxel—pancreatic cancer	0.0004	0.0105	CcSEcCtD
Cyclopentolate—Lacrimation increased—Doxorubicin—pancreatic cancer	0.000397	0.0104	CcSEcCtD
Cyclopentolate—Flushing—Irinotecan—pancreatic cancer	0.000396	0.0104	CcSEcCtD
Cyclopentolate—Convulsion—Sunitinib—pancreatic cancer	0.00039	0.0103	CcSEcCtD
Cyclopentolate—Dry mouth—Sunitinib—pancreatic cancer	0.000375	0.00986	CcSEcCtD
Cyclopentolate—Coordination abnormal—Doxorubicin—pancreatic cancer	0.000373	0.0098	CcSEcCtD
Cyclopentolate—Coma—Epirubicin—pancreatic cancer	0.000362	0.00951	CcSEcCtD
Cyclopentolate—Vision blurred—Fluorouracil—pancreatic cancer	0.000335	0.0088	CcSEcCtD
Cyclopentolate—Coma—Doxorubicin—pancreatic cancer	0.000335	0.00879	CcSEcCtD
Cyclopentolate—Vertigo—Irinotecan—pancreatic cancer	0.000333	0.00876	CcSEcCtD
Cyclopentolate—Conjunctivitis—Docetaxel—pancreatic cancer	0.000319	0.00839	CcSEcCtD
Cyclopentolate—Convulsion—Fluorouracil—pancreatic cancer	0.000308	0.00809	CcSEcCtD
Cyclopentolate—Pruritus—Tamoxifen—pancreatic cancer	0.000304	0.00798	CcSEcCtD
Cyclopentolate—Pruritus—Erlotinib—pancreatic cancer	0.0003	0.0079	CcSEcCtD
Cyclopentolate—Tachycardia—Fluorouracil—pancreatic cancer	0.000283	0.00744	CcSEcCtD
Cyclopentolate—Flushing—Docetaxel—pancreatic cancer	0.000273	0.00719	CcSEcCtD
Cyclopentolate—Rash—Tamoxifen—pancreatic cancer	0.000271	0.00711	CcSEcCtD
Cyclopentolate—Dermatitis—Tamoxifen—pancreatic cancer	0.00027	0.00711	CcSEcCtD
Cyclopentolate—Ataxia—Epirubicin—pancreatic cancer	0.00027	0.0071	CcSEcCtD
Cyclopentolate—Somnolence—Irinotecan—pancreatic cancer	0.000269	0.00708	CcSEcCtD
Cyclopentolate—Rash—Erlotinib—pancreatic cancer	0.000268	0.00704	CcSEcCtD
Cyclopentolate—Dermatitis—Erlotinib—pancreatic cancer	0.000268	0.00703	CcSEcCtD
Cyclopentolate—Somnolence—Gemcitabine—pancreatic cancer	0.000262	0.00689	CcSEcCtD
Cyclopentolate—Pruritus—Sunitinib—pancreatic cancer	0.00026	0.00684	CcSEcCtD
Cyclopentolate—Somnolence—Fluorouracil—pancreatic cancer	0.000258	0.00678	CcSEcCtD
Cyclopentolate—Abdominal distension—Epirubicin—pancreatic cancer	0.00025	0.00657	CcSEcCtD
Cyclopentolate—Ataxia—Doxorubicin—pancreatic cancer	0.00025	0.00657	CcSEcCtD
Cyclopentolate—Rash—Sunitinib—pancreatic cancer	0.000232	0.00609	CcSEcCtD
Cyclopentolate—Dermatitis—Sunitinib—pancreatic cancer	0.000232	0.00609	CcSEcCtD
Cyclopentolate—Abdominal distension—Doxorubicin—pancreatic cancer	0.000231	0.00608	CcSEcCtD
Cyclopentolate—Convulsion—Docetaxel—pancreatic cancer	0.000222	0.00584	CcSEcCtD
Cyclopentolate—Drowsiness—Epirubicin—pancreatic cancer	0.000221	0.00582	CcSEcCtD
Cyclopentolate—Conjunctivitis—Epirubicin—pancreatic cancer	0.000215	0.00566	CcSEcCtD
Cyclopentolate—Dry mouth—Docetaxel—pancreatic cancer	0.000214	0.00561	CcSEcCtD
Cyclopentolate—Pruritus—Gemcitabine—pancreatic cancer	0.000209	0.00549	CcSEcCtD
Cyclopentolate—Pruritus—Fluorouracil—pancreatic cancer	0.000205	0.00539	CcSEcCtD
Cyclopentolate—Drowsiness—Doxorubicin—pancreatic cancer	0.000205	0.00538	CcSEcCtD
Cyclopentolate—Tachycardia—Docetaxel—pancreatic cancer	0.000204	0.00537	CcSEcCtD
Cyclopentolate—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000199	0.00523	CcSEcCtD
Cyclopentolate—Rash—Irinotecan—pancreatic cancer	0.000191	0.00502	CcSEcCtD
Cyclopentolate—Dermatitis—Irinotecan—pancreatic cancer	0.000191	0.00501	CcSEcCtD
Cyclopentolate—Somnolence—Docetaxel—pancreatic cancer	0.000186	0.00489	CcSEcCtD
Cyclopentolate—Rash—Gemcitabine—pancreatic cancer	0.000186	0.00489	CcSEcCtD
Cyclopentolate—Dermatitis—Gemcitabine—pancreatic cancer	0.000186	0.00488	CcSEcCtD
Cyclopentolate—Flushing—Epirubicin—pancreatic cancer	0.000184	0.00485	CcSEcCtD
Cyclopentolate—Rash—Fluorouracil—pancreatic cancer	0.000183	0.00481	CcSEcCtD
Cyclopentolate—Dermatitis—Fluorouracil—pancreatic cancer	0.000183	0.0048	CcSEcCtD
Cyclopentolate—Flushing—Doxorubicin—pancreatic cancer	0.000171	0.00449	CcSEcCtD
Cyclopentolate—Vision blurred—Epirubicin—pancreatic cancer	0.000163	0.00429	CcSEcCtD
Cyclopentolate—Agitation—Epirubicin—pancreatic cancer	0.000159	0.00418	CcSEcCtD
Cyclopentolate—Vertigo—Epirubicin—pancreatic cancer	0.000155	0.00409	CcSEcCtD
Cyclopentolate—Vision blurred—Doxorubicin—pancreatic cancer	0.000151	0.00397	CcSEcCtD
Cyclopentolate—Convulsion—Epirubicin—pancreatic cancer	0.00015	0.00394	CcSEcCtD
Cyclopentolate—Pruritus—Docetaxel—pancreatic cancer	0.000148	0.00389	CcSEcCtD
Cyclopentolate—Agitation—Doxorubicin—pancreatic cancer	0.000147	0.00387	CcSEcCtD
Cyclopentolate—Dry mouth—Epirubicin—pancreatic cancer	0.000144	0.00379	CcSEcCtD
Cyclopentolate—Vertigo—Doxorubicin—pancreatic cancer	0.000144	0.00378	CcSEcCtD
Cyclopentolate—Convulsion—Doxorubicin—pancreatic cancer	0.000139	0.00365	CcSEcCtD
Cyclopentolate—Tachycardia—Epirubicin—pancreatic cancer	0.000138	0.00362	CcSEcCtD
Cyclopentolate—Dry mouth—Doxorubicin—pancreatic cancer	0.000133	0.0035	CcSEcCtD
Cyclopentolate—Rash—Docetaxel—pancreatic cancer	0.000132	0.00347	CcSEcCtD
Cyclopentolate—Dermatitis—Docetaxel—pancreatic cancer	0.000132	0.00347	CcSEcCtD
Cyclopentolate—Tachycardia—Doxorubicin—pancreatic cancer	0.000128	0.00335	CcSEcCtD
Cyclopentolate—Somnolence—Epirubicin—pancreatic cancer	0.000126	0.0033	CcSEcCtD
Cyclopentolate—Somnolence—Doxorubicin—pancreatic cancer	0.000116	0.00305	CcSEcCtD
Cyclopentolate—Pruritus—Epirubicin—pancreatic cancer	9.99e-05	0.00263	CcSEcCtD
Cyclopentolate—Pruritus—Doxorubicin—pancreatic cancer	9.24e-05	0.00243	CcSEcCtD
Cyclopentolate—Rash—Epirubicin—pancreatic cancer	8.9e-05	0.00234	CcSEcCtD
Cyclopentolate—Dermatitis—Epirubicin—pancreatic cancer	8.89e-05	0.00234	CcSEcCtD
Cyclopentolate—Rash—Doxorubicin—pancreatic cancer	8.24e-05	0.00217	CcSEcCtD
Cyclopentolate—Dermatitis—Doxorubicin—pancreatic cancer	8.23e-05	0.00216	CcSEcCtD
Cyclopentolate—CHRM3—Signaling Pathways—ZNRF3—pancreatic cancer	7.11e-05	0.00107	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.91e-05	0.00104	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PTHLH—pancreatic cancer	6.9e-05	0.00103	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PTHLH—pancreatic cancer	6.88e-05	0.00103	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GLP1R—pancreatic cancer	6.75e-05	0.00101	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—DPYD—pancreatic cancer	6.64e-05	0.000996	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—SHH—pancreatic cancer	6.61e-05	0.000991	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—SHH—pancreatic cancer	6.59e-05	0.000988	CbGpPWpGaD
Cyclopentolate—CHRM1—Regulation of Actin Cytoskeleton—PIK3CA—pancreatic cancer	6.57e-05	0.000984	CbGpPWpGaD
Cyclopentolate—CHRM3—Regulation of Actin Cytoskeleton—PIK3CA—pancreatic cancer	6.54e-05	0.000981	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IAPP—pancreatic cancer	6.53e-05	0.000979	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IAPP—pancreatic cancer	6.51e-05	0.000976	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SSTR3—pancreatic cancer	6.45e-05	0.000967	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—DTX1—pancreatic cancer	6.45e-05	0.000967	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—TYMP—pancreatic cancer	6.44e-05	0.000966	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SSTR3—pancreatic cancer	6.43e-05	0.000963	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—DTX1—pancreatic cancer	6.43e-05	0.000963	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—SST—pancreatic cancer	6.31e-05	0.000946	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—SLC2A2—pancreatic cancer	6.3e-05	0.000945	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—SST—pancreatic cancer	6.29e-05	0.000943	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PTHLH—pancreatic cancer	6.27e-05	0.00094	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PTCH1—pancreatic cancer	6.27e-05	0.00094	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PTHLH—pancreatic cancer	6.25e-05	0.000937	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PTCH1—pancreatic cancer	6.25e-05	0.000937	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.24e-05	0.000935	CbGpPWpGaD
Cyclopentolate—BCHE—Transmission across Chemical Synapses—HRAS—pancreatic cancer	6.22e-05	0.000933	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	6.19e-05	0.000928	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SSTR1—pancreatic cancer	6.18e-05	0.000927	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	6.17e-05	0.000925	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SSTR1—pancreatic cancer	6.16e-05	0.000924	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PPY—pancreatic cancer	6.06e-05	0.000909	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PPY—pancreatic cancer	6.04e-05	0.000906	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.02e-05	0.000903	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SSTR2—pancreatic cancer	5.95e-05	0.000892	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SSTR2—pancreatic cancer	5.93e-05	0.000889	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—CNR1—pancreatic cancer	5.83e-05	0.000873	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—CNR1—pancreatic cancer	5.81e-05	0.000871	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCKBR—pancreatic cancer	5.75e-05	0.000861	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—SST—pancreatic cancer	5.73e-05	0.000859	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCKBR—pancreatic cancer	5.73e-05	0.000859	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	5.71e-05	0.000857	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—SST—pancreatic cancer	5.71e-05	0.000857	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	5.7e-05	0.000854	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	5.64e-05	0.000846	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—GCG—pancreatic cancer	5.63e-05	0.000844	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	5.62e-05	0.000843	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—GCG—pancreatic cancer	5.61e-05	0.000841	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.48e-05	0.000822	CbGpPWpGaD
Cyclopentolate—CHRM1—G alpha (q) signalling events—PIK3CA—pancreatic cancer	5.47e-05	0.000821	CbGpPWpGaD
Cyclopentolate—CHRM3—G alpha (q) signalling events—PIK3CA—pancreatic cancer	5.46e-05	0.000818	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—DTX4—pancreatic cancer	5.4e-05	0.00081	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GLI1—pancreatic cancer	5.4e-05	0.00081	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—DTX4—pancreatic cancer	5.39e-05	0.000807	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GLI1—pancreatic cancer	5.39e-05	0.000807	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AGTR1—pancreatic cancer	5.37e-05	0.000805	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AGTR1—pancreatic cancer	5.35e-05	0.000802	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	5.33e-05	0.000799	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	5.31e-05	0.000796	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CNR1—pancreatic cancer	5.29e-05	0.000793	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CNR1—pancreatic cancer	5.27e-05	0.000791	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PPP2R5B—pancreatic cancer	5.26e-05	0.000788	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NRP1—pancreatic cancer	5.26e-05	0.000788	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NRP1—pancreatic cancer	5.24e-05	0.000785	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PPP2R5B—pancreatic cancer	5.24e-05	0.000785	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GLP1R—pancreatic cancer	5.19e-05	0.000778	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—GCG—pancreatic cancer	5.11e-05	0.000766	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—DPYD—pancreatic cancer	5.11e-05	0.000766	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—GCG—pancreatic cancer	5.09e-05	0.000764	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HEY2—pancreatic cancer	5.06e-05	0.000758	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HEY2—pancreatic cancer	5.04e-05	0.000756	CbGpPWpGaD
Cyclopentolate—CHRM1—Circadian rythm related genes—TP53—pancreatic cancer	5e-05	0.000749	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GAST—pancreatic cancer	4.94e-05	0.000741	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GAST—pancreatic cancer	4.93e-05	0.000738	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	4.9e-05	0.000734	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CD44—pancreatic cancer	4.88e-05	0.000732	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	4.88e-05	0.000732	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AGTR1—pancreatic cancer	4.87e-05	0.000731	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AGTR1—pancreatic cancer	4.86e-05	0.000728	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—SLC2A2—pancreatic cancer	4.85e-05	0.000727	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.78e-05	0.000717	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—MMP2—pancreatic cancer	4.78e-05	0.000716	CbGpPWpGaD
Cyclopentolate—BCHE—Neuronal System—HRAS—pancreatic cancer	4.77e-05	0.000715	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.74e-05	0.00071	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SCT—pancreatic cancer	4.68e-05	0.000702	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HEY1—pancreatic cancer	4.68e-05	0.000702	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GCG—pancreatic cancer	4.68e-05	0.000702	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SCT—pancreatic cancer	4.67e-05	0.0007	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HEY1—pancreatic cancer	4.67e-05	0.0007	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	4.53e-05	0.000679	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	4.52e-05	0.000677	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCK—pancreatic cancer	4.47e-05	0.00067	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCK—pancreatic cancer	4.45e-05	0.000668	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—STK11—pancreatic cancer	4.4e-05	0.00066	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CNR2—pancreatic cancer	4.35e-05	0.000653	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GLP1R—pancreatic cancer	4.35e-05	0.000653	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—CXCL8—pancreatic cancer	4.35e-05	0.000652	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CNR2—pancreatic cancer	4.34e-05	0.000651	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GLP1R—pancreatic cancer	4.34e-05	0.000651	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—CXCL8—pancreatic cancer	4.34e-05	0.00065	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCKAR—pancreatic cancer	4.28e-05	0.000642	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCKAR—pancreatic cancer	4.27e-05	0.00064	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—JAG2—pancreatic cancer	4.15e-05	0.000623	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—JAG2—pancreatic cancer	4.14e-05	0.000621	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.13e-05	0.000619	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MEN1—pancreatic cancer	4.09e-05	0.000614	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MEN1—pancreatic cancer	4.08e-05	0.000612	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—CXCL8—pancreatic cancer	3.97e-05	0.000595	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SHH—pancreatic cancer	3.91e-05	0.000586	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SHH—pancreatic cancer	3.89e-05	0.000584	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOTCH4—pancreatic cancer	3.88e-05	0.000582	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOTCH4—pancreatic cancer	3.87e-05	0.00058	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IAPP—pancreatic cancer	3.86e-05	0.000578	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IAPP—pancreatic cancer	3.84e-05	0.000576	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—TYMS—pancreatic cancer	3.78e-05	0.000567	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CD44—pancreatic cancer	3.75e-05	0.000563	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PTHLH—pancreatic cancer	3.7e-05	0.000555	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PTCH1—pancreatic cancer	3.7e-05	0.000555	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PTHLH—pancreatic cancer	3.69e-05	0.000553	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PTCH1—pancreatic cancer	3.69e-05	0.000553	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—CTNNB1—pancreatic cancer	3.66e-05	0.000549	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GCG—pancreatic cancer	3.6e-05	0.000539	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SST—pancreatic cancer	3.39e-05	0.000508	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—STK11—pancreatic cancer	3.38e-05	0.000507	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SST—pancreatic cancer	3.38e-05	0.000506	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.34e-05	0.000501	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.33e-05	0.000499	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—JAG1—pancreatic cancer	3.31e-05	0.000497	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—JAG1—pancreatic cancer	3.3e-05	0.000495	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOTCH3—pancreatic cancer	3.3e-05	0.000495	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOTCH3—pancreatic cancer	3.29e-05	0.000493	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CNR1—pancreatic cancer	3.13e-05	0.000469	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CNR1—pancreatic cancer	3.12e-05	0.000467	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—APOE—pancreatic cancer	3.08e-05	0.000461	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	3.03e-05	0.000455	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PIK3CG—pancreatic cancer	3.02e-05	0.000453	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GCG—pancreatic cancer	3.02e-05	0.000453	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GCG—pancreatic cancer	3.01e-05	0.000451	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.94e-05	0.00044	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.93e-05	0.000439	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.91e-05	0.000437	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—TYMS—pancreatic cancer	2.91e-05	0.000436	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AGTR1—pancreatic cancer	2.88e-05	0.000432	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	2.87e-05	0.00043	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—STK11—pancreatic cancer	2.84e-05	0.000425	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—STK11—pancreatic cancer	2.83e-05	0.000424	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PIK3CG—pancreatic cancer	2.78e-05	0.000416	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PPARG—pancreatic cancer	2.68e-05	0.000402	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	2.67e-05	0.0004	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	2.66e-05	0.000398	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.56e-05	0.000384	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.55e-05	0.000382	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SMAD4—pancreatic cancer	2.49e-05	0.000373	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	2.48e-05	0.000371	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.46e-05	0.000369	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	2.45e-05	0.000368	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PIK3CD—pancreatic cancer	2.44e-05	0.000366	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HES1—pancreatic cancer	2.43e-05	0.000364	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HES1—pancreatic cancer	2.42e-05	0.000363	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—APOE—pancreatic cancer	2.37e-05	0.000355	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.32e-05	0.000348	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	2.32e-05	0.000347	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CXCL8—pancreatic cancer	2.23e-05	0.000335	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	2.23e-05	0.000334	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PIK3CG—pancreatic cancer	2.14e-05	0.00032	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PIK3CB—pancreatic cancer	2.13e-05	0.000319	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TERT—pancreatic cancer	2.13e-05	0.000319	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TERT—pancreatic cancer	2.12e-05	0.000318	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PTGS2—pancreatic cancer	2.11e-05	0.000316	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PPARG—pancreatic cancer	2.06e-05	0.000309	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HIF1A—pancreatic cancer	2.03e-05	0.000305	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TSC2—pancreatic cancer	2.03e-05	0.000304	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	2.03e-05	0.000304	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	2.02e-05	0.000303	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APOE—pancreatic cancer	1.99e-05	0.000298	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APOE—pancreatic cancer	1.98e-05	0.000297	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KDR—pancreatic cancer	1.95e-05	0.000292	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KDR—pancreatic cancer	1.94e-05	0.000291	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PIK3CD—pancreatic cancer	1.88e-05	0.000282	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	1.85e-05	0.000277	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	1.84e-05	0.000276	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PTEN—pancreatic cancer	1.84e-05	0.000276	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	1.83e-05	0.000275	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	1.83e-05	0.000274	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	1.79e-05	0.000269	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	1.79e-05	0.000269	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	1.79e-05	0.000268	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	1.79e-05	0.000268	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EGF—pancreatic cancer	1.77e-05	0.000266	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EGF—pancreatic cancer	1.77e-05	0.000265	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PIK3CB—pancreatic cancer	1.64e-05	0.000245	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	1.63e-05	0.000245	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	1.63e-05	0.000244	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PTGS2—pancreatic cancer	1.62e-05	0.000243	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	1.58e-05	0.000236	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	1.57e-05	0.000235	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.56e-05	0.000234	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.56e-05	0.000233	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	1.54e-05	0.000231	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	1.54e-05	0.00023	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.42e-05	0.000212	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PTEN—pancreatic cancer	1.41e-05	0.000212	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	1.41e-05	0.000212	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	1.37e-05	0.000206	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	1.37e-05	0.000205	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	1.32e-05	0.000198	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	1.32e-05	0.000197	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	1.31e-05	0.000197	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	1.31e-05	0.000196	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PIK3CA—pancreatic cancer	1.3e-05	0.000195	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	1.27e-05	0.000191	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	1.27e-05	0.00019	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	1.26e-05	0.000189	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	1.26e-05	0.000189	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	1.23e-05	0.000184	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	1.23e-05	0.000184	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	1.22e-05	0.000182	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	1.21e-05	0.000182	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	1.19e-05	0.000179	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	1.19e-05	0.000178	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	1.19e-05	0.000178	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	1.18e-05	0.000177	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	1.16e-05	0.000174	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	1.15e-05	0.000173	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SRC—pancreatic cancer	1.1e-05	0.000165	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SRC—pancreatic cancer	1.1e-05	0.000164	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	1.07e-05	0.000161	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	1.07e-05	0.00016	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	1.06e-05	0.000159	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—AKT1—pancreatic cancer	1.06e-05	0.000159	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	1.06e-05	0.000159	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	1.06e-05	0.000159	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	1.06e-05	0.000158	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PIK3CA—pancreatic cancer	9.98e-06	0.00015	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MYC—pancreatic cancer	9.86e-06	0.000148	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	9.84e-06	0.000147	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MYC—pancreatic cancer	9.83e-06	0.000147	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	9.8e-06	0.000147	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	9.64e-06	0.000145	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	9.61e-06	0.000144	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	9.11e-06	0.000137	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	9.08e-06	0.000136	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	8.37e-06	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	8.34e-06	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—AKT1—pancreatic cancer	8.15e-06	0.000122	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TP53—pancreatic cancer	8.1e-06	0.000121	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TP53—pancreatic cancer	8.07e-06	0.000121	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	7.74e-06	0.000116	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	7.72e-06	0.000116	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	6.84e-06	0.000103	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	6.82e-06	0.000102	CbGpPWpGaD
